Navigation Links
Accuray Incorporated to Speak at 2011 Wedbush Life Sciences: Management Access Conference

SUNNYVALE, Calif., Aug. 9, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Wedbush Life Sciences: Management Access Conference in New York on Wednesday, August 17, 2011 at 9:10 a.m. ET/6:10 a.m. PT.

A live webcast of the presentation will be available online from the investor relations page of the Company's Web site at The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company. Accuray develops, manufactures and sells personalized, best-in-class treatment solutions that revolve around the patient. Accuray's game-changing technologies – the CyberKnife System and TomoTherapy Systems – set the standard of care with the aim of helping patients live longer, better lives. To date, more than 200,000 patients worldwide have been treated using the company's technologies and more than 550 systems have been installed in leading hospitals around the world. For more information, please visit

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Euan Thomson, Ph.D.

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. SEC Declares Accuray Form S-4 Registration Statement Effective in Proposed Acquisition of TomoTherapy
2. Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2011
3. Accuray Incorporated to Speak at Seventh Annual Lazard Capital Markets Healthcare Conference
4. Accuray Incorporated to Speak at Wells Fargo Securities Healthcare Conference
5. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
6. Accuray Incorporated to Present at Robert Baird 2009 Healthcare Conference
7. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
8. 10 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service
9. Accuray Incorporated to Report Second Quarter Fiscal Year 2009 Financial Results
10. Accuray Incorporateds CEO to Speak at 27th Annual JP Morgan Healthcare Conference
11. Accuray Achieves Milestone of 150th CyberKnife System Installed Worldwide
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... uBiome, were featured on AngelList early in their initial angel funding process. Now, ... syndicate for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
(Date:11/24/2015)... Israel , Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) ... on December 29, 2015 at 11:00 a.m. Israel ... Electra Tower, 98 Yigal Allon Street, 36 th Floor, ... of Eric Paneth and Izhak Tamir to the ... Rami Skaliter as external directors; , approval of an amendment to ...
Breaking Biology Technology:
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
Breaking Biology News(10 mins):